Medicare Enrolled

Dr. Michael Jacobson, M.D.

Ophthalmology · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1100 JOHNSON FERRY RD NE, Atlanta, GA 30342
4042559096
Registered in NPPES since 2005
NPI: 1376546549 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jacobson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jacobson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jacobson

Dr. Michael Jacobson is an ophthalmology specialist in Atlanta, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Jacobson performed 30,988 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Jacobson received a total of $41,583 from 25 pharmaceutical and/or device companies across 314 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jacobson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 2% volume in GA $41,583 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
30,988
Medicare services
Top 2% in GA for ophthalmology
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
26,760 $29 $107
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,163 $32 $129
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
843 $93 $1,320
Aflibercept eye injection (Eylea) 572 $684 $2,100
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
448 $93 $255
Injection, ranibizumab, 0.1 mg 314 $181 $1,082
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
286 $120 $292
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
224 $157 $372
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
109 $66 $175
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
109 $27 $200
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
78 $19 $111
New patient office visit, complex (60-74 min) 28 $177 $525
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
23 $123 $400
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
17 $111 $350
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
14 $36 $361
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$41,583
Total received (2018-2024)
Avg $5,940/year across 7 years
Top 6% in GA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
314
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,181
2023
$2,138
2022
$13,051
2021
$14,414
2020
$3,676
2019
$5,558
2018
$1,565

Payments by company (2024)

Bausch & Lomb Americas Inc.
$312
Astellas Pharma US Inc
$216
Apellis Pharmaceuticals, Inc.
$194
Regeneron Healthcare Solutions, Inc.
$159
ABBVIE INC.
$92
Alimera Sciences, Inc.
$80
Genentech USA, Inc.
$75
EyePoint Pharmaceuticals US, Inc.
$29
Halozyme Inc
$25
Top 3 companies account for 61.1% of 2024 payments
All-time payments by company (2018-2024) ›
US Retina LLC
$28,868
Alimera Sciences, Inc.
$2,620
Genentech USA, Inc.
$1,978
Regeneron Healthcare Solutions, Inc.
$1,648
Allergan Inc.
$959
Notal Vision, Inc.
$665
Astellas Pharma US Inc
$661
Apellis Pharmaceuticals, Inc.
$650
Novartis Pharmaceuticals Corporation
$607
Alcon Vision LLC
$515
ABBVIE INC.
$488
Carl Zeiss Meditec USA, Inc.
$381
Bausch & Lomb Americas Inc.
$312
Allergan, Inc.
$250
Bausch & Lomb, a division of Bausch Health US, LLC
$214
Dutch Ophthalmic, USA
$127
Genentech, Inc.
$125
Regeneron Pharmaceuticals, Inc.
$123
Shire North American Group Inc
$116
EyePoint Pharmaceuticals US, Inc.
$79
Coherus Biosciences Inc.
$64
NEW WORLD MEDICAL,INC.
$48
Kala Pharmaceuticals, Inc.
$42
Halozyme Inc
$25
Sun Pharmaceutical Industries Inc.
$19
Top 3 companies account for 80.5% of all-time payments
Associated products mentioned in payments ›
Ahmed Glaucoma Valve · BEOVU · CIRRUS HD-OCT · CLARUS · CLARUS 700 · Cimerli · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · HYLENEX RECOMBINANT · ILUMYA · ILUVIEN · INVELTYS · Iluvien · Izervay · LOTEMAX · LOTEMAX SM · Lucentis · NGENUITY · OZURDEX · PROLENSA · SUSVIMO · Syfovre · VABYSMO · VISUDYNE · Vabysmo · XIIDRA · XIPERE · YUTIQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Atlanta?
Compare ophthalmologists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
263
County median income
$91,490
Nearest hospital to ZIP centroid (approximate)
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jacobson is a mixed practice specialist, with above-average Medicare volume (top 2% in GA), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Jacobson experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Jacobson performed 26,760 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jacobson receive payments from pharmaceutical companies?
Yes. Dr. Jacobson received a total of $41,583 from 25 companies across 314 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jacobson's costs compare to other ophthalmologists in Atlanta?
Dr. Jacobson's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jacobson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →